Case of Vaccine-Induced Immune Thrombocytopenia in a Baby
Author Information
Author(s): Khadayat Ramesh, Shrestha Sailesh, Gautam Tilak, Magar Sagar Rana, Bhatta Prashant
Primary Institution: Patan Hospital Patan Academy of Health Science Lalitpur Nepal
Hypothesis
Can the Pentavalent vaccine trigger immune thrombocytopenia in infants?
Conclusion
The case highlights that immune thrombocytopenia can occur following the Pentavalent vaccine, emphasizing the need for awareness among healthcare providers.
Supporting Evidence
- Immune thrombocytopenia is a rare autoimmune disorder that can be triggered by various factors, including vaccines.
- The child showed symptoms of petechial rashes and mucosal bleeding after receiving the Pentavalent vaccine.
- Platelet counts were critically low at 7.5 thousand/μL, confirming severe thrombocytopenia.
- Treatment involved platelet transfusion and monitoring, leading to recovery.
- Parents should be educated about the potential risks of vaccines, including rare side effects like ITP.
Takeaway
A baby developed a serious condition called immune thrombocytopenia after getting a vaccine, which shows that vaccines can sometimes cause unexpected problems.
Methodology
The case involved a clinical evaluation of a 3-month-old male who developed symptoms after vaccination, followed by blood tests to confirm thrombocytopenia.
Potential Biases
Potential reporting bias in vaccine-associated adverse events.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
3-month-old male infant.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website